Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/41579
Title: | Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial | Authors: | Lingvay, Ildiko Harris, Stewart Jaeckel, Elmar Chandarana, Keval Ranthe, Mattis F Jódar Gimeno, Esteban |
UNESCO Clasification: | 32 Ciencias médicas 320502 Endocrinología |
Keywords: | IDegLira Body mass index Clinical trial Insulin therapy Type 2 diabetes |
Issue Date: | 2018 | Journal: | Diabetes, Obesity and Metabolism | Abstract: | This study assessed the efficacy of insulin degludec/liraglutide (IDegLira) vs insulin glargine U100 (IGlar) across categories of baseline glycated haemoglobin (HbA1c; ≤7.5%, >7.5% to ≤8.5% and >8.5%), body mass index (BMI; <30, ≥30 to <35 and ≥35 kg/m2 ) and fasting plasma glucose (FPG; <7.2 and ≥7.2 mmol/L) in patients with type 2 diabetes (T2D) uncontrolled on basal insulin, using post hoc analyses of the DUAL V 26-week trial. With IDegLira, mean HbA1c was reduced across all baseline HbA1c (1.0%-2.5%), FPG (1.5%-1.9%) and BMI categories (1.8%-1.9%), with significantly greater reductions compared with IGlar U100. For all HbA1c, FPG and BMI categories, IDegLira resulted in weight loss and IGlar U100 in weight gain; hypoglycaemia rates were lower for IDegLira vs IGlar U100. More patients achieved HbA1c <7% with IDegLira than IGlar U100 across all HbA1c (59%-87% vs 31%-66%), FPG (71%-74% vs 40%-51%) and BMI categories (71%-73% vs 40%-54%). IDegLira improved glycaemic control and induced weight loss in patients with T2D previously uncontrolled on basal insulin, across the categories of baseline HbA1c, FPG or BMI that were tested. | URI: | http://hdl.handle.net/10553/41579 | ISSN: | 1463-1326 | DOI: | 10.1111/dom.13043 | Source: | Diabetes, Obesity and Metabolism [ISSN 1463-1326], v. 20 (1). p. 200-205 | URL: | https://api.elsevier.com/content/abstract/scopus_id/85026461534 |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
14
checked on Aug 25, 2024
WEB OF SCIENCETM
Citations
13
checked on Aug 25, 2024
Page view(s)
21
checked on Mar 9, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.